tradingkey.logo
tradingkey.logo
Search

US FDA publishes 200 rejection letters in transparency push

ReutersJul 10, 2025 1:11 PM
facebooktwitterlinkedin
View all comments0

- The U.S. Food and Drug Administration on Thursday published more than 200 of its so-called complete response letters to drugmakers, a significant move to increase transparency of the agency's work.

The published letters were issued in response to marketing applications of certain drugs or therapies submitted to the FDA between 2020 and 2024.

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Comments (0)

Click the $ button, enter the symbol, and select to link a stock, ETF, or other ticker.

0/500
Commenting Guidelines
Loading...

Recommended Articles

Tradingkey
KeyAI